BlackRock, Fidelity Inject $297.6M into U.S. Spot Bitcoin ETFs

BlackRock’s IBIT and Fidelity’s FBTC led $297.56 million of inflows into U.S. spot Bitcoin ETFs on Aug. 18, reversing three straight sessions of net outflows.

On Aug. 18, 2026, U.S. spot Bitcoin exchange-traded funds recorded $297.56 million in net inflows, reversing three consecutive sessions of net outflows. BlackRock’s IBIT received $160.23 million and Fidelity’s FBTC took in $111.90 million. ARK 21Shares’ ARKB added $14.18 million and Morgan Stanley’s MSBT reported $11.24 million. Trading value across the Bitcoin ETFs for the session reached $2.12 billion and combined net assets closed at $77.41 billion.

Institutional holdings accompanied the inflows. Quantitative trading firm Jane Street disclosed more than $1 billion in U.S. spot Bitcoin ETF holdings as of June 30, including roughly $828 million in IBIT and smaller positions in other products. Harvard Management Company maintained an IBIT position of 3,044,612 shares valued at $101.4 million as of June 30, unchanged from the prior quarter after two earlier reductions.

Ether exchange-traded products also posted inflows of $30.85 million. BlackRock’s ETHA accounted for $25.90 million, Fidelity’s FETH added $4.27 million and Bitwise’s ETHW received about $682,000. No Ether ETF reported a net outflow during the session. Combined trading value across Ether ETFs was $459.73 million and their combined net assets closed at $10.59 billion.

Smaller altcoin-focused ETFs were largely inactive. Solana, XRP and HYPE funds reported no net creations or redemptions for the session, leaving most allocation activity concentrated in Bitcoin and Ether products.

The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.

Articles by this author